Drug Safety Test
The drug development process proceeds in a stepwise manner while evaluating the efficacy and safety information obtained from animals and humans. The nonclinical safety assessment aims to characterize toxicity in terms of target organs, dose dependency, relationship to exposure, and where appropriate, reversibility. This information is used to estimate the safe starting dose and dose range for the first in-human study and identify parameters for monitoring adverse effects in the clinical setting. Nonclinical safety studies conducted before the start of clinical development are usually limited; however, adverse effects that may appear under the conditions of clinical studies must be fully clarified.
FUJIFILM Wako offer various reagents and kits such as toxicity study, pharmacokinetic study, and mutagenicity study.
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.